<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35227168</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>02</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>04</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1743-2928</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>27</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Redox report : communications in free radical research</Title>
          <ISOAbbreviation>Redox Rep</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Psychostimulants influence oxidative stress and redox signatures: the role of DNA methylation.</ArticleTitle>
        <Pagination>
          <StartPage>53</StartPage>
          <EndPage>59</EndPage>
          <MedlinePgn>53-59</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/13510002.2022.2043224</ELocationID>
        <Abstract>
          <AbstractText><b>Objective:</b> Psychostimulant use induces oxidative stress and alters redox imbalance, influencing epigenetic signatures in the central nervous system (CNS). Among the various epigenetic changes, DNA methylation is directly linked to oxidative stress metabolism via critical redox intermediates such as NAD+, S-adenosylmethionine (SAM), and 2-oxoglutarate. Fluctuations in these intermediates directly influence epigenetic signatures, which leads to detectable alterations in gene expression and protein modification. This review focuses on recent advances in the impact of psychostimulant use on redox-imbalance-induced DNA methylation to develop novel epigenetics-based early interventions. <b>Methods:</b> This review is based on collective research data obtained from the PubMed, Science Direct, and Medline databases. The keywords used in the electronic search in these databases were redox, substance use disorder, psychostimulants, DNA methylation, and neurological diseases. <b>Results:</b> Instability in DNA methylation levels and redox expression effects are reported in various behavioral models stimulated by psychostimulants and opioids, indicating the widespread involvement of epigenetic changes in DNA methylation signatures in neurological disorders. <b>Discussion:</b> This review summarizes the need for more studies and experimental evaluations of DNA-methylation-based strategies that may help to understand the association between psychostimulant use and oxidative stress or redox-linked metabolic recalibration influencing neuronal impairments.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Sundar</LastName>
            <ForeName>Vaishnavi</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmaceutical Sciences, Irma Lerma Rangel College of Pharmacy, Texas A&amp;M University, Kingsville, Texas, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ramasamy</LastName>
            <ForeName>Tamizhselvi</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmaceutical Sciences, Irma Lerma Rangel College of Pharmacy, Texas A&amp;M University, Kingsville, Texas, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>School of Biosciences and Technology, Vellore Institute of Technology, Vellore, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Doke</LastName>
            <ForeName>Mayur</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmaceutical Sciences, Irma Lerma Rangel College of Pharmacy, Texas A&amp;M University, Kingsville, Texas, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Samikkannu</LastName>
            <ForeName>Thangavel</ForeName>
            <Initials>T</Initials>
            <Identifier Source="ORCID">0000-0001-5071-056X</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pharmaceutical Sciences, Irma Lerma Rangel College of Pharmacy, Texas A&amp;M University, Kingsville, Texas, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Redox Rep</MedlineTA>
        <NlmUniqueID>9511366</NlmUniqueID>
        <ISSNLinking>1351-0002</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000697">Central Nervous System Stimulants</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000697" MajorTopicYN="Y">Central Nervous System Stimulants</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019175" MajorTopicYN="Y">DNA Methylation</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D044127" MajorTopicYN="N">Epigenesis, Genetic</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Psychostimulants</Keyword>
        <Keyword MajorTopicYN="N">cocaine</Keyword>
        <Keyword MajorTopicYN="N">epigenetics</Keyword>
        <Keyword MajorTopicYN="N">methamphetamine</Keyword>
        <Keyword MajorTopicYN="N">methylation</Keyword>
        <Keyword MajorTopicYN="N">neurodegeneration</Keyword>
        <Keyword MajorTopicYN="N">opioids</Keyword>
        <Keyword MajorTopicYN="N">redox changes</Keyword>
      </KeywordList>
      <CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>1</Day>
          <Hour>5</Hour>
          <Minute>42</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35227168</ArticleId>
        <ArticleId IdType="pmc">PMC8890556</ArticleId>
        <ArticleId IdType="doi">10.1080/13510002.2022.2043224</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Hansford B. UNODC World Drug Report 2021: pandemic effects ramp up drug risks, as youth underestimate cannabis dangers. 2021 Jun 24; 2021:1.</Citation>
        </Reference>
        <Reference>
          <Citation>Cyr AR, Domann FE.. 
The redox basis of epigenetic modifications: from mechanisms to functional consequences. Antioxidants Redox Signal. 2011;15:551–89. doi:10.1089/ars.2010.3492.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/ars.2010.3492</ArticleId>
            <ArticleId IdType="pmc">PMC3118659</ArticleId>
            <ArticleId IdType="pubmed">20919933</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trivedi M, Deth R.. 
A redox/methylation hypothesis of drug addiction. Front Neurosci. 2014;8:1–14. doi:10.3389/fnins.2014.00444.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fnins.2014.00444</ArticleId>
            <ArticleId IdType="pubmed">0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Adibhatla RM, Hatcher JF.. 
Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal. 2010;12:125–69.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19624272</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamamoto BK, Raudensky J.. 
The role of oxidative stress, metabolic compromise, and inflammation in neuronal injury produced by amphetamine-related drugs of abuse. J Neuroimmune Pharmacol. 2008;3:203–17. doi:10.1007/s11481-008-9121-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11481-008-9121-7</ArticleId>
            <ArticleId IdType="pmc">PMC3955110</ArticleId>
            <ArticleId IdType="pubmed">18709468</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berríos-Cárcamo P, Quezada M, Quintanilla ME, et al. . 
Oxidative stress and neuroinflammation as a pivot in drug abuse. A focus on the therapeutic potential of antioxidant and anti-inflammatory agents and biomolecules. Antioxidants. 2020;9:1–26. doi:10.3390/antiox9090830.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/antiox9090830</ArticleId>
            <ArticleId IdType="pmc">PMC7555323</ArticleId>
            <ArticleId IdType="pubmed">32899889</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nielsen DA, Utrankar A, Reyes JA, et al. . 
Epigenetics of drug abuse: predisposition or response. Pharmacogenomics. 2012;13:1149–60.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3463407</ArticleId>
            <ArticleId IdType="pubmed">22909205</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sivalingam K, Doke M, Khan MA, et al. . 
Influence of psychostimulants and opioids on epigenetic modification of class III histone deacetylase (HDAC)-sirtuins in glial cells. Sci Rep. 2021;11:1–16. doi:10.1038/s41598-021-00836-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-021-00836-z</ArticleId>
            <ArticleId IdType="pmc">PMC8556237</ArticleId>
            <ArticleId IdType="pubmed">34716387</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mahna D, Puri S, Sharma S.. 
Dna methylation signatures: biomarkers of drug and alcohol abuse. Mutat Res Mutat Res. 2018;777:19–28.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30115428</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ciccarone D.
Stimulant abuse: pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy. Prim Care Clin Off Pract. 2011;38:41–58.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3056348</ArticleId>
            <ArticleId IdType="pubmed">21356420</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trivedi M, Shah J, Hodgson N, et al. . 
Morphine induces redox-based changes in global DNA methylation and retrotransposon transcription by inhibition of excitatory amino acid transporter type 3-mediated cysteine uptake. Mol Pharmacol. 2014;85:747–57. doi:10.1124/mol.114.091728.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1124/mol.114.091728</ArticleId>
            <ArticleId IdType="pmc">PMC3990020</ArticleId>
            <ArticleId IdType="pubmed">24569088</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Doke M, Pendyala G, Samikkannu T.. 
Psychostimulants and opioids differentially influence the epigenetic modification of histone acetyltransferase and histone deacetylase in astrocytes. PLoS One. 2021;16:e0252895.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8195369</ArticleId>
            <ArticleId IdType="pubmed">34115777</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Limanaqi F, Gambardella S, Biagioni F, et al. . 
Epigenetic effects induced by methamphetamine and methamphetamine-dependent oxidative stress. Oxid Med Cell Longev. 2018;2018; doi:10.1155/2018/4982453.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2018/4982453</ArticleId>
            <ArticleId IdType="pmc">PMC6081569</ArticleId>
            <ArticleId IdType="pubmed">30140365</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wei H, Liang F, Meng G, et al.  Redox_methylation mediated abnormal DNA methylation as regulators of ambient fine particulate matter-induced neurodevelopment related impairment in human neuronal cells _ Enhanced Reader.pdf n.d.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5022064</ArticleId>
            <ArticleId IdType="pubmed">27624276</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miller CA, Campbell SL, Sweatt JD.. 
Dna methylation and histone acetylation work in concert to regulate memory formation and synaptic plasticity. Neurobiol Learn Mem. 2008;89:599–603.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2430891</ArticleId>
            <ArticleId IdType="pubmed">17881251</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miller CA, Gavin CF, White JA, et al. . 
Cortical DNA methylation maintains remote memory. Nat Neurosci. 2010;13:664–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3043549</ArticleId>
            <ArticleId IdType="pubmed">20495557</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shrestha S, Offer SM.. 
Epigenetic regulations of GABAergic neurotransmission: relevance for neurological disorders and epigenetic therapy. Med Epigenetics. 2016;4:1–19. doi:10.1159/000444713.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000444713</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tanda G, Pontieri FE, Di Chiara G.. 
Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common µ1 opioid receptor mechanism. Science. 1997;276:2048–50.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9197269</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuepper R, Morrison PD, van Os J, et al. . 
Does dopamine mediate the psychosis-inducing effects of cannabis? A review and integration of findings across disciplines. Schizophr Res. 2010;121:107–17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20580531</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Y, Loonam TM NOAILLESP, Angulo JA.. 
Comparison of cocaine-and methamphetamine-evoked dopamine and glutamate overflow in somatodendritic and terminal field regions of the rat brain during acute, chronic, and early withdrawal conditions. Ann N Y Acad Sci. 2001;937:93–120.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11458542</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bateman JT, Saunders SE, Levitt ES.. 
Understanding and countering opioid-induced respiratory depression. Br J Pharmacol. 2021.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34089181</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Volkow ND, Fowler JS, Wang G-J, et al. . 
Dopamine in drug abuse and addiction. Arch Neurol. 2007;64:1575. doi:10.1001/archneur.64.11.1575.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archneur.64.11.1575</ArticleId>
            <ArticleId IdType="pubmed">17998440</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Daniel E Shumer NJNNPS . 乳鼠心肌提取 HHS Public access. Physiol Behav. 2017;176:139–48. doi:10.1111/ejn.14130.Targeting.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/ejn.14130.Targeting</ArticleId>
            <ArticleId IdType="pubmed">0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Muratore CR, Hodgson NW, Trivedi MS, et al. . 
Age-dependent decrease and alternative splicing of methionine synthase mRNA in human cerebral cortex and an accelerated decrease in autism. PLoS One. 2013;8:e56927.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3577685</ArticleId>
            <ArticleId IdType="pubmed">23437274</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trivedi M, Zhang Y, Lopez-Toledano M, et al. . 
Differential neurogenic effects of casein-derived opioid peptides on neuronal stem cells: implications for redox-based epigenetic changes. J Nutr Biochem. 2016;37:39–46.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27611101</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Durmaz A, Dikmen N.. 
Homocysteine effects on cellular glutathione peroxidase (GPx-1) activity under in vitro conditions. J Enzyme Inhib Med Chem. 2007;22:733–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18237028</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weiss N, Heydrick SJ, Postea O, et al.  Influence of hyperhomocysteinemia on the cellular redox state–impact on homocysteine-induced endothelial dysfunction 2003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14656025</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Uys JD, Mulholland PJ, Townsend DM.. 
Glutathione and redox signaling in substance abuse. Biomed Pharmacother. 2014;68:799–807.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4455547</ArticleId>
            <ArticleId IdType="pubmed">25027386</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cunha-Oliveira T, Cristina Rego A, Oliveira C R.. 
Oxidative stress and drugs of abuse: an update. Mini Rev Org Chem. 2013;10:321–34.</Citation>
        </Reference>
        <Reference>
          <Citation>Himi T, Ikeda M, Yasuhara T, et al. . 
Role of neuronal glutamate transporter in the cysteine uptake and intracellular glutathione levels in cultured cortical neurons. J Neural Transm. 2003;110:1337–48.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14666406</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen Y, Swanson RA.. 
The glutamate transporters EAAT2 and EAAT3 mediate cysteine uptake in cortical neuron cultures. J Neurochem. 2003;84:1332–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12614333</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luchsinger JA, Tang M-X, Shea S, et al. . 
Plasma homocysteine levels and risk of Alzheimer disease. Neurology. 2004;62:1972–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15184599</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu H, Wicker NJ, Shaw GM, et al. . 
Homocysteine remethylation enzyme polymorphisms and increased risks for neural tube defects. Mol Genet Metab. 2003;78:216–21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12649067</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ryter SW, Kim HP, Hoetzel A, et al. . 
Mechanisms of cell death in oxidative stress. Antioxid Redox Signal. 2007;9:49–89.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17115887</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marinelli M, Cooper DC, Baker LK, et al. . 
Impulse activity of midbrain dopamine neurons modulates drug-seeking behavior. Psychopharmacology (Berl). 2003;168:84–98.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12721782</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xi Z-X, Newman AH, Gilbert JG, et al. . 
The novel dopamine D 3 receptor antagonist NGB 2904 inhibits cocaine’s rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats. Neuropsychopharmacology. 2006;31:1393–405.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16205781</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bao L, Avshalumov M V, Patel JC, et al. . 
Mitochondria are the source of hydrogen peroxide for dynamic brain-cell signaling. J Neurosci. 2009;29:9002–10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2892101</ArticleId>
            <ArticleId IdType="pubmed">19605638</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sims NR, Anderson MF, Hobbs LM, et al. . 
Impairment of brain mitochondrial function by hydrogen peroxide. Mol Brain Res. 2000;77:176–84.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10837913</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miyazaki I, Asanuma M.. 
Approaches to prevent dopamine quinone-induced neurotoxicity. Neurochem Res. 2009;34:698–706.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18770028</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Badillo-Ramírez I, Saniger JM, Rivas-Arancibia S.. 
5-S-cysteinyl-dopamine, a neurotoxic endogenous metabolite of dopamine: implications for Parkinson’s disease. Neurochem Int. 2019;129:104514.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31369776</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dagnino-Subiabre A, Cassels BK, Baez S, et al. . 
Glutathione transferase M2-2 catalyzes conjugation of dopamine and dopa o-quinones. Biochem Biophys Res Commun. 2000;274:32–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10903891</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Munoz P, Huenchuguala S, Paris I, et al. . 
Dopamine oxidation and autophagy. Park Dis. 2012;2012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3433151</ArticleId>
            <ArticleId IdType="pubmed">22966478</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Womersley JS, Townsend DM, Kalivas PW, et al. . 
Targeting redox regulation to treat substance use disorder using N-acetylcysteine. Eur J Neurosci. 2019;50:2538–51.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6387857</ArticleId>
            <ArticleId IdType="pubmed">30144182</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hongpaisan J, Winters CA, Andrews SB.. 
Strong calcium entry activates mitochondrial superoxide generation, upregulating kinase signaling in hippocampal neurons. J Neurosci. 2004;24:10878–87.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6730216</ArticleId>
            <ArticleId IdType="pubmed">15574738</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim HY, Lee KY, Lu Y, et al. . 
Mitochondrial Ca2+ uptake is essential for synaptic plasticity in pain. J Neurosci. 2011;31:12982–91.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3179262</ArticleId>
            <ArticleId IdType="pubmed">21900577</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim M-S, Usachev YM.. 
Mitochondrial Ca2+ cycling facilitates activation of the transcription factor NFAT in sensory neurons. J Neurosci. 2009;29:12101–14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2805078</ArticleId>
            <ArticleId IdType="pubmed">19793968</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jang EY, Ryu Y, Lee BH, et al. . 
Involvement of reactive oxygen species in cocaine-taking behaviors in rats. Addict Biol. 2015;20:663–75.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4843775</ArticleId>
            <ArticleId IdType="pubmed">24975938</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beiser T, Yaka R.. 
The role of oxidative stress in cocaine addiction. J Neurol Neuromedicine. 2019;4.</Citation>
        </Reference>
        <Reference>
          <Citation>Bu Q, Lv L, Yan G, et al. . 
NMR-based metabonomic in hippocampus, nucleus accumbens and prefrontal cortex of methamphetamine-sensitized rats. Neurotoxicology. 2013;36:17–23.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23462569</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kita T, Matsunari Y, Saraya T, et al. . 
Methamphetamine-induced striatal dopamine release, behavior changes and neurotoxicity in BALB/c mice. Int J Dev Neurosci. 2000;18:521–30.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10884597</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lord KC, Shenouda SK, McIlwain E, et al. . 
Oxidative stress contributes to methamphetamine-induced left ventricular dysfunction. Cardiovasc Res. 2010;87:111–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2883898</ArticleId>
            <ArticleId IdType="pubmed">20139112</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cadet JL, Sheng P, All S, et al. . 
Rapid communication: attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice. J Neurochem. 1994;62:380–3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7505315</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang MC, Lin SK, Chen CH, et al. . 
Oxidative stress status in recently abstinent methamphetamine abusers. Psychiatry Clin Neurosci. 2013;67:92–100. doi:10.1111/pcn.12025.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/pcn.12025</ArticleId>
            <ArticleId IdType="pubmed">23438161</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jayanthi S, Ladenheim B, Cadet JL.. 
Methamphetamine-induced changes in antioxidant enzymes and lipid peroxidation in copper/zinc-superoxide dismutase transgenic mice. Ann N Y Acad Sci. 1998;844:92–102.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29090838</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meng X, Zhang C, Guo Y, et al. . 
TBHQ attenuates neurotoxicity induced by methamphetamine in the VTA through the Nrf2/HO-1 and PI3K/AKT signaling pathways. Oxid Med Cell Longev. 2020;2020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7174937</ArticleId>
            <ArticleId IdType="pubmed">32351675</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schattauer SS, Bedini A, Summers F, et al. . 
Reactive oxygen species (ROS) generation is stimulated by opioid receptor activation through phosphorylated c-Jun N-terminal kinase and inhibited by p38 mitogen-activated protein kinase (MAPK) activation. J Biol Chem. 2019;294:16884–96. doi:10.1074/jbc.RA119.009592.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.RA119.009592</ArticleId>
            <ArticleId IdType="pmc">PMC6851317</ArticleId>
            <ArticleId IdType="pubmed">31575661</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maresca A, Del Dotto V, Capristo M, et al. . 
Dnmt1 mutations leading to neurodegeneration paradoxically reflect on mitochondrial metabolism. Hum Mol Genet. 2020;29:1864–81. doi:10.1093/hmg/ddaa014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddaa014</ArticleId>
            <ArticleId IdType="pmc">PMC7372549</ArticleId>
            <ArticleId IdType="pubmed">31984424</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hodgson N, Trivedi M, Muratore C, et al. . 
Soluble oligomers of amyloid-β cause changes in redox state, DNA methylation, and gene transcription by inhibiting EAAT3 mediated cysteine uptake. J Alzheimer’s Dis. 2013;36:197–209.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23579332</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Islam MT.
Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders. Neurol Res. 2017;39:73–82. doi:10.1080/01616412.2016.1251711.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/01616412.2016.1251711</ArticleId>
            <ArticleId IdType="pubmed">27809706</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim Y, Connor JR.. 
The roles of iron and HFE genotype in neurological diseases. Mol Aspects Med. 2020;100867.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32654761</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nandar W, Connor JR.. 
Hfe gene variants affect iron in the brain. J Nutr. 2011;141:729S–739S.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21346098</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ye Q, Trivedi M, Zhang Y, et al. . 
Brain iron loading impairs DNA methylation and alters GABAergic function in mice. FASEB J. 2019;33:2460–71.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6338660</ArticleId>
            <ArticleId IdType="pubmed">30277817</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roy CN, Blemings KP, Deck KM, et al. . 
Increased IRP1 and IRP2 RNA binding activity accompanies a reduction of the labile iron pool in HFE-expressing cells. J Cell Physiol. 2002;190:218–26.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11807826</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ersahin M, Toklu HZ, Çetinel Ş, et al. . 
Melatonin reduces experimental subarachnoid hemorrhage-induced oxidative brain damage and neurological symptoms. J Pineal Res. 2009;46:324–32.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19215574</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chang J, Zhang B, Heath H, et al. . 
Nicotinamide adenine dinucleotide (NAD)–regulated DNA methylation alters CCCTC-binding factor (CTCF)/cohesin binding and transcription at the BDNF locus. Proc Natl Acad Sci. 2010;107:21836–41.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3003122</ArticleId>
            <ArticleId IdType="pubmed">21106760</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Im H-I, Hollander JA, Bali P, et al. . 
Mecp2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212. Nat Neurosci. 2010;13:1120–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2928848</ArticleId>
            <ArticleId IdType="pubmed">20711185</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen WG, Chang Q, Lin Y, et al. . 
Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science. 2003;302:885–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14593183</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kietzmann T, Petry A, Shvetsova A, et al. . 
The epigenetic landscape related to reactive oxygen species formation in the cardiovascular system. Br J Pharmacol. 2017;174:1533–54.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5446579</ArticleId>
            <ArticleId IdType="pubmed">28332701</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eskandari MR, Rahmati M, Khajeamiri AR, et al. . 
A new approach on methamphetamine-induced hepatotoxicity: involvement of mitochondrial dysfunction. Xenobiotica. 2014;44:70–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23786375</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beckhauser TF, Francis-Oliveira J, De Pasquale R.. 
Reactive oxygen species: physiological and physiopathological effects on synaptic plasticity: supplementary issue: brain plasticity and repair. J Exp Neurosci. 2016;10:JEN-S39887.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5012454</ArticleId>
            <ArticleId IdType="pubmed">27625575</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cadet JL, Bisagno V.. 
Glial-neuronal ensembles: partners in drug addiction-associated synaptic plasticity. Front Pharmacol. 2014;5:204.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4151032</ArticleId>
            <ArticleId IdType="pubmed">25228881</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anier K, Zharkovsky A, Kalda A.. 
S-adenosylmethionine modifies cocaine-induced DNA methylation and increases locomotor sensitization in mice. Int J Neuropsychopharmacol. 2013;16:2053–66.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23684129</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu Q, Xia S, Lin J, et al. . 
Effects of the altered activity of δ-opioid receptor on the expression of glutamate transporter type 3 induced by chronic exposure to morphine. J Neurol Sci. 2013;335:174–81.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24120272</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mavencamp TL, Rhoderick JF, Bridges RJ, et al. . 
Synthesis and preliminary pharmacological evaluation of novel derivatives of L-β-threo-benzylaspartate as inhibitors of the neuronal glutamate transporter EAAT3. Bioorg Med Chem. 2008;16:7740–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2631431</ArticleId>
            <ArticleId IdType="pubmed">18650095</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spiers JG, Breda C, Robinson S, et al. . 
Drosophila Nrf2/Keap1 mediated redox signaling supports synaptic function and longevity and impacts on circadian activity. Front Mol Neurosci. 2019;12(86).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6476960</ArticleId>
            <ArticleId IdType="pubmed">31040766</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morales DX, Grineski SE, Collins TW.. 
乳鼠心肌提取 HHS Public access. Physiol Behav. 2016;176:139–48. doi:10.1111/ejn.14130.Targeting.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/ejn.14130.Targeting</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peterson EC, Gentry WB, Owens SM.. 
Customizing monoclonal antibodies for the treatment of methamphetamine abuse: current and future applications. Adv Pharmacol. 2014;69:107–27. doi:10.1016/B978-0-12-420118-7.00003-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/B978-0-12-420118-7.00003-2</ArticleId>
            <ArticleId IdType="pmc">PMC4491432</ArticleId>
            <ArticleId IdType="pubmed">24484976</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Andrade C.
Sustained-release, extended-release, and other time-release formulations in neuropsychiatry. J Clin Psychiatry. 2015;76:e995–9. doi:10.4088/JCP.15f10219.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4088/JCP.15f10219</ArticleId>
            <ArticleId IdType="pubmed">26335096</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sagar V, Atluri VSR, Pilakka-Kanthikeel S, et al. . 
Magnetic nanotherapeutics for dysregulated synaptic plasticity during neuroAIDS and drug abuse. Mol Brain. 2016;9:1–10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4878083</ArticleId>
            <ArticleId IdType="pubmed">27216740</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He M, Li Z, Ge Y, et al. . 
Portable upconversion nanoparticles-based paper device for field testing of drug abuse. Anal Chem. 2016;88:1530–4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26786499</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
